ReproCELL Incorporated

REPROCELL, founded in 2003, has extensive and accumulated capabilities in iPS cells. As a pioneer with a global outreach in USA, UK, and India, we continue to drive science and applications in research, drug discovery, and regenerative medicine projects. We also provide biospecimens, preclinical assay services using fresh human tissues, and molecular services, and continue to be a unique tool provider for drug discovery workflow.